Where Indian investors think together
Community feed, AI-powered stock screener, personalised news, and SEBI-verified Research Analyst insights — built for Indian retail investors.
Free to download · No credit card required · 5 AI analyses/day free
5,000+
Stocks Covered
8+
News Sources
1–10
AI View Score
100%
SEBI Compliant
Four reasons to switch
Everything you need to invest smarter
Community
Post ideas, follow traders you trust, tag stocks with @SYMBOL, react to moves in real-time. The stock market finally has a social layer built for Indian investors.
Personalised News
All major sources — ET, CNBC, Moneycontrol, TOI — in one place. Our AI ranks stories by your portfolio, watchlist, and reading habits. Premium members also get OB Narrative: deep-context market analysis.
AI Screener
Search any NSE/BSE stock and get an AI View score (1–10), Bullish/Bearish label, structured Pros & Cons, technical analysis (RSI, MACD, EMA), and fundamentals. Free users get 5 analyses/day.
Research Analysts
Follow only SEBI-registered Research Analysts. Every piece of advice is tagged with the analyst's SEBI registration number. Free users get 2 insights/day; Premium gets unlimited access.
For serious traders
Portfolio tracking built for active traders
Add holdings, track real-time P&L, view risk-to-reward ratio, accuracy, and risk appetite gauges — all in your Trader Profile. Your portfolio dashboard, built into a social app.
SEBI-Compliant Research Analyst Section
All Research Analysts on Obridge are verified under SEBI (Research Analyst) Regulations, 2014. Every piece of RA content displays the analyst's SEBI registration number. Our AI never issues buy/sell calls — it provides structured informational analysis only.
Read full disclaimer →Ready to invest with your community?
Join thousands of Indian investors on Obridge. Free to download, free to start.
Investments in securities markets are subject to market risks. Read all related documents carefully before investing. Obridge does not provide investment advice. Past performance is not indicative of future results.